Hye Ryun Kim
A Yonsei oncologist who has led checkpoint-inhibitor and combination trials in lung and head-and-neck cancer.
Hye Ryun Kim's work includes immunotherapy biomarker studies and trials of PD-1 combinations in NSCLC and head-and-neck squamous cell carcinoma.
Pages like this
not linked directly; found by shared links- InstitutionZhejiang Cancer Hospital
Shares Head and neck squamous cell carcinoma, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- PersonLillian L. Siu
Shares Head and neck squamous cell carcinoma, Immune checkpoint inhibitors.
- PersonVanita Noronha
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
- IdeaProtect hearing from cisplatin in adults as we now do in children
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
- PersonCharu Aggarwal
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
- InstitutionShandong Cancer Hospital and Institute
Shares Head and neck squamous cell carcinoma, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- TrialJAVELIN Head and Neck 100
Shares Head and neck squamous cell carcinoma, Immune checkpoint inhibitors.
- InstitutionApollo Hospitals (Apollo Cancer Centres)
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer.